PRME
Price
$4.00
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
44 days until earnings call
VYGR
Price
$6.24
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
48 days until earnings call
Ad is loading...

PRME vs VYGR

Header iconPRME vs VYGR Comparison
Open Charts PRME vs VYGRBanner chart's image
Prime Medicine
Price$4.00
Change-$0.00 (-0.00%)
Volume$834.04K
CapitalizationN/A
Voyager Therapeutics
Price$6.24
Change-$0.00 (-0.00%)
Volume$467.26K
CapitalizationN/A
View a ticker or compare two or three
PRME vs VYGR Comparison Chart
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PRME vs. VYGR commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Hold and VYGR is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (PRME: $4.00 vs. VYGR: $6.24)
Brand notoriety: PRME and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 136% vs. VYGR: 121%
Market capitalization -- PRME: $480.12M vs. VYGR: $340.29M
PRME [@Biotechnology] is valued at $480.12M. VYGR’s [@Biotechnology] market capitalization is $340.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 6 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • PRME’s TA Score: 6 bullish, 2 bearish.
  • VYGR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRME is a better buy in the short-term than VYGR.

Price Growth

PRME (@Biotechnology) experienced а 0.00% price change this week, while VYGR (@Biotechnology) price change was +0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

PRME is expected to report earnings on Nov 01, 2024.

VYGR is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($480M) has a higher market cap than VYGR($340M). VYGR YTD gains are higher at: -26.066 vs. PRME (-54.853). VYGR has higher annual earnings (EBITDA): -1.78M vs. PRME (-204.68M). VYGR has more cash in the bank: 371M vs. PRME (163M). PRME has less debt than VYGR: PRME (41.6M) vs VYGR (46.9M). VYGR has higher revenues than PRME: VYGR (144M) vs PRME (591K).
PRMEVYGRPRME / VYGR
Capitalization480M340M141%
EBITDA-204.68M-1.78M11,473%
Gain YTD-54.853-26.066210%
P/E RatioN/A23.11-
Revenue591K144M0%
Total Cash163M371M44%
Total Debt41.6M46.9M89%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMEVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 15 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
PRME
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SRICX12.210.02
+0.16%
Gabelli SRI C
PRPZX8.510.01
+0.12%
PGIM Jennison MLP Z
POLIX46.85N/A
N/A
Polen Growth Institutional
TEMPX8.23N/A
N/A
Nuveen Emerging Markets Eq Prem
GSTRX9.28N/A
N/A
Goldman Sachs Strategic Growth R

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been closely correlated with NTLA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRME jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+6.95%
NTLA - PRME
68%
Closely correlated
+4.83%
BEAM - PRME
65%
Loosely correlated
-0.16%
ABCL - PRME
58%
Loosely correlated
+1.87%
CRSP - PRME
58%
Loosely correlated
+4.46%
ALLO - PRME
56%
Loosely correlated
+4.35%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+0.16%
NTLA - VYGR
46%
Loosely correlated
+4.83%
PLRX - VYGR
44%
Loosely correlated
+6.15%
ELVN - VYGR
44%
Loosely correlated
-4.07%
XNCR - VYGR
44%
Loosely correlated
-0.52%
PRME - VYGR
43%
Loosely correlated
+6.95%
More